Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sunil Sharma

Showing results (321-330 of 429) with videos related to

Pageof 43
Sort By:
Plos One|August 27, 2015
Targeting Artificial Tumor Stromal Targets for Molecular Imaging of Tumor Vascular HypoxiaNathan A Koonce, Joseph Levy, Matthew E Hardee, et al.
Technology in Cancer Research & Treatment|March 31, 2017
Study of Image Qualities From 6D Robot-Based CBCT Imaging System of Small Animal IrradiatorSunil Sharma, Ganesh Narayanasamy, Richard Clarkson, et al.
Behavioural Brain Research|May 5, 2023
Rat BM-MSCs secretome alone and in combination with stiripentol and ISRIB, ameliorated microglial activation and apoptosis in experimental strokeNeha Dhir, Ashish Jain, Amit Raj Sharma, et al.
Cancer Chemotherapy and Pharmacology|February 13, 2013
Phase I study to assess the pharmacokinetics and the effect on cardiac repolarization of amrubicin and amrubicinol in patients with advanced solid tumorsNianhang Chen, Sant P Chawla, Elena Gabriela Chiorean, et al.
Drug and Chemical Toxicology|January 3, 2023
Genotoxic and mutagenic potential of 7-methylxanthine: an investigational drug molecule for the treatment of myopiaHarjeet Singh, Harmanpreet Singh, Sunil Sharma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 2021
A Phase 1a/b Open-Label, Dose-Escalation Study of Etigilimab Alone or in Combination with Nivolumab in Patients with Locally Advanced or Metastatic Solid TumorsNiharika B Mettu, Susanna V Ulahannan, Johanna C Bendell, et al.
Investigational New Drugs|October 11, 2018
Phase I/II study of everolimus combined with mFOLFOX-6 and bevacizumab for first-line treatment of metastatic colorectal cancerG Weldon Gilcrease, David D Stenehjem, Mark L Wade, et al.
Cancer Chemotherapy and Pharmacology|June 28, 2011
Effect of ketoconazole-mediated CYP3A4 inhibition on clinical pharmacokinetics of panobinostat (LBH589), an orally active histone deacetylase inhibitorPaul Hamberg, Margaret M Woo, Lin-Chi Chen, et al.
Molecular and Cellular Biology|March 9, 2016
SUMOylation Regulates Growth Factor Independence 1 in Transcriptional Control and HematopoiesisDaniel Andrade, Matthew Velinder, Jason Singer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 8, 2013
Phase II study of everolimus in patients with metastatic colorectal adenocarcinoma previously treated with bevacizumab-, fluoropyrimidine-, oxaliplatin-, and irinotecan-based regimensKimmie Ng, Josep Tabernero, Jimmy Hwang, et al.
Pageof 43

Showing results (321-330 of 429) with videos related to

Sort By:
Pageof 43
Plos One|August 27, 2015
Targeting Artificial Tumor Stromal Targets for Molecular Imaging of Tumor Vascular HypoxiaNathan A Koonce, Joseph Levy, Matthew E Hardee, et al.
Technology in Cancer Research & Treatment|March 31, 2017
Study of Image Qualities From 6D Robot-Based CBCT Imaging System of Small Animal IrradiatorSunil Sharma, Ganesh Narayanasamy, Richard Clarkson, et al.
Behavioural Brain Research|May 5, 2023
Rat BM-MSCs secretome alone and in combination with stiripentol and ISRIB, ameliorated microglial activation and apoptosis in experimental strokeNeha Dhir, Ashish Jain, Amit Raj Sharma, et al.
Cancer Chemotherapy and Pharmacology|February 13, 2013
Phase I study to assess the pharmacokinetics and the effect on cardiac repolarization of amrubicin and amrubicinol in patients with advanced solid tumorsNianhang Chen, Sant P Chawla, Elena Gabriela Chiorean, et al.
Drug and Chemical Toxicology|January 3, 2023
Genotoxic and mutagenic potential of 7-methylxanthine: an investigational drug molecule for the treatment of myopiaHarjeet Singh, Harmanpreet Singh, Sunil Sharma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 2021
A Phase 1a/b Open-Label, Dose-Escalation Study of Etigilimab Alone or in Combination with Nivolumab in Patients with Locally Advanced or Metastatic Solid TumorsNiharika B Mettu, Susanna V Ulahannan, Johanna C Bendell, et al.
Investigational New Drugs|October 11, 2018
Phase I/II study of everolimus combined with mFOLFOX-6 and bevacizumab for first-line treatment of metastatic colorectal cancerG Weldon Gilcrease, David D Stenehjem, Mark L Wade, et al.
Cancer Chemotherapy and Pharmacology|June 28, 2011
Effect of ketoconazole-mediated CYP3A4 inhibition on clinical pharmacokinetics of panobinostat (LBH589), an orally active histone deacetylase inhibitorPaul Hamberg, Margaret M Woo, Lin-Chi Chen, et al.
Molecular and Cellular Biology|March 9, 2016
SUMOylation Regulates Growth Factor Independence 1 in Transcriptional Control and HematopoiesisDaniel Andrade, Matthew Velinder, Jason Singer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 8, 2013
Phase II study of everolimus in patients with metastatic colorectal adenocarcinoma previously treated with bevacizumab-, fluoropyrimidine-, oxaliplatin-, and irinotecan-based regimensKimmie Ng, Josep Tabernero, Jimmy Hwang, et al.
Pageof 43